Soricimed Biopharma Inc.
Soricimed Biopharma Inc. (formerly BioProspecting NB Inc.), is dedicated to advancing its therapeutic and diagnostic programs. Soricimed is a private drug and diagnostic development company created in 2005 following the discovery and development of a proprietary peptide, soricidin. Soricidin is the basis for Soricimed’s targeted cancer management program focused on an ovarian cancer therapeutic and a companion early diagnostic. Using focused innovative strategies in collaboration with major world-class cancer research institutions, Soricimed’s drugs have demonstrated a capability to reduce cell viability, induce apoptosis and to reduce tumour volume with no demonstrable toxicity. The company works out of our state-of-the-art lab in Sackville, New Brunswick, Canada.